The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kronos Bio Inc(NASDAQ:KRON) 
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of new cancer therapies. The company is headquartered in San Mateo, California.
Website: https://www.kronosbio.com/
Founded: 2017
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends
Kronos Bio Days Payable Outstanding ttm (DPO)
Kronos Bio Days Receivable Outstanding ttm (DSO)
Kronos Bio Days Inventory Outstanding ttm (DIO)
Kronos Bio Op Cashflow Per Share ttm
Kronos Bio Free Cashflow Per Share ttm
Kronos Bio Cash Per Share ttm
Kronos Bio P/S ratio ttm
Kronos Bio (GAAP) P/E ratio ttm
Kronos Bio P/B ratio ttm
No extra charts and metrics for this ticker.